August 27, 2009in Commercialization, Patentability, Pharmaceutical Drugs0by Editor1552 Should Exclusivity Periods be Tailored to Technology? On Friday, July 31st, the United States House Committee on Energy and Commerce approved “America’s Affordable Health Choices Act” by a narrow three-vote margin. The bill was introduced in the…
